Torrent Pharmaceuticals Limited has submitted a regulatory disclosure to BSE Limited and National Stock Exchange of India Ltd. regarding its scheduled participation in investor meetings. The disclosure is made in pursuance of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The company has provided a detailed schedule of three investor meetings where its representatives will participate:
- 17-Sep-26: Jefferies India forum 2026 in Gurgaon (Group and one on one meetings)
- 18-Sep-26: Kotak Healthcare Forum 2026 in Mumbai (Group and one on one meetings)
- 21-Sep-26: JP Morgan India Conference in Mumbai (Group and one on one meetings)
The disclosure includes an important qualification that the schedule is subject to change due to any exigencies on the part of the company or the investors.
The letter was digitally signed by CHINTAN M TRIVEDI, Company Secretary, on September 10, 2026, at 17:11:17 IST.